EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Methodological Concerns in TNFAIP3, IRAK1, and TLR4 Polymorphism Analysis for RA Susceptibility

Aditya K Panda iD

Immunity, Inflammation and Disease · 2026-05 · 14 (5)

DOI: 10.1002/iid3.70426 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 21.05.2026. Verfasst von Aditya K Panda. Beteiligte Einrichtung: ImmGen EvSys Lab, BT-113, Department of Biotechnology, Berhampur University, Berhampur, Odisha, India. Die Arbeit nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • ImmGen EvSys Lab, BT-113, Department of Biotechnology, Berhampur University, Berhampur, Odisha, India.
  • Centre of Excellence on Bioprospecting of Ethno-Pharmaceuticals of Southern Odisha (CoE-BESO), Berhampur University, Berhampur, Odisha, India.

ORCID-Profile: Aditya K Panda

Zitieren

APA

Panda, A. K. (2026). Methodological Concerns in TNFAIP3, IRAK1, and TLR4 Polymorphism Analysis for RA Susceptibility. Immunity, Inflammation and Disease, 14(5). https://doi.org/10.1002/iid3.70426

Vancouver

Panda AK. Methodological Concerns in TNFAIP3, IRAK1, and TLR4 Polymorphism Analysis for RA Susceptibility. Immunity, Inflammation and Disease. 2026;14(5). doi:10.1002/iid3.70426

BibTeX
@article{Panda2026,
  author = {Panda, Aditya K},
  title = {Methodological Concerns in TNFAIP3, IRAK1, and TLR4 Polymorphism Analysis for RA Susceptibility},
  journal = {Immunity, Inflammation and Disease},
  year = {2026},
  volume = {14},
  number = {5},
  doi = {10.1002/iid3.70426}
}
Kostenlos starten →